{"id":23924,"date":"2025-10-13T15:37:27","date_gmt":"2025-10-13T13:37:27","guid":{"rendered":"https:\/\/www.unither-pharma.com\/?post_type=faq&#038;p=23924"},"modified":"2026-01-06T13:19:24","modified_gmt":"2026-01-06T12:19:24","slug":"quappelle-t-on-maladie-orpheline","status":"publish","type":"faq","link":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/","title":{"rendered":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ?"},"content":{"rendered":"<p>Une maladie orpheline, aussi appel\u00e9e maladie rare, est une pathologie qui touche un nombre tr\u00e8s limit\u00e9 de patients. En Europe, elle est d\u00e9finie comme une maladie affectant moins d\u2019une personne sur 2 000.<br \/>\nCes maladies n\u00e9cessitent souvent des traitements sp\u00e9cifiques, peu disponibles, ce qui implique une production pharmaceutique adapt\u00e9e et en faibles volumes.<\/p>\n","protected":false},"menu_order":0,"template":"","meta":{"_acf_changed":false},"class_list":["post-23924","faq","type-faq","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither<\/title>\n<meta name=\"description\" content=\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither\" \/>\n<meta property=\"og:description\" content=\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/\" \/>\n<meta property=\"og:site_name\" content=\"Unither\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-06T12:19:24+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@UnitherPharma\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/\",\"name\":\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither\",\"isPartOf\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\"},\"datePublished\":\"2025-10-13T13:37:27+00:00\",\"dateModified\":\"2026-01-06T12:19:24+00:00\",\"description\":\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither\",\"breadcrumb\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.unither-pharma.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#website\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"name\":\"Unither\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#organization\",\"name\":\"Unither\",\"url\":\"https:\/\/www.unither-pharma.com\/fr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"contentUrl\":\"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png\",\"width\":514,\"height\":252,\"caption\":\"Unither\"},\"image\":{\"@id\":\"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/UnitherPharma\",\"https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/\",\"https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","description":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/","og_locale":"fr_FR","og_type":"article","og_title":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","og_description":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","og_url":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/","og_site_name":"Unither","article_modified_time":"2026-01-06T12:19:24+00:00","twitter_card":"summary_large_image","twitter_site":"@UnitherPharma","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/","url":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/","name":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","isPartOf":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#website"},"datePublished":"2025-10-13T13:37:27+00:00","dateModified":"2026-01-06T12:19:24+00:00","description":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ? | Unither","breadcrumb":{"@id":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.unither-pharma.com\/fr\/faq\/quappelle-t-on-maladie-orpheline\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.unither-pharma.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Pourquoi la production de m\u00e9dicaments pour maladies rares n\u00e9cessite-t-elle une CDMO experte en petits lots ?"}]},{"@type":"WebSite","@id":"https:\/\/www.unither-pharma.com\/fr\/#website","url":"https:\/\/www.unither-pharma.com\/fr\/","name":"Unither","description":"","publisher":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.unither-pharma.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.unither-pharma.com\/fr\/#organization","name":"Unither","url":"https:\/\/www.unither-pharma.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","contentUrl":"https:\/\/www.unither-pharma.com\/wp-content\/uploads\/2026\/01\/logo-unither-pharmaceuticals-site-internet.png","width":514,"height":252,"caption":"Unither"},"image":{"@id":"https:\/\/www.unither-pharma.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/UnitherPharma","https:\/\/www.linkedin.com\/company\/unither-pharmaceuticals\/","https:\/\/www.youtube.com\/channel\/UCHaTbYrnICFU1MiLwNsKjMA"]}]}},"_links":{"self":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/faq\/23924","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/faq"}],"about":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/types\/faq"}],"wp:attachment":[{"href":"https:\/\/www.unither-pharma.com\/fr\/wp-json\/wp\/v2\/media?parent=23924"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}